(Reuters) -Drugmaker Regeneron Pharmaceuticals is acquiring majority assets of bankrupt genetic testing firm 23andMe Holding for $256 million. The once-sizzling DNA-testing startup filed for ...
The story of bringing dire wolves back from extinction begins not in a laboratory, but in ancient deposits where their remains lay buried for millennia. The genetic material that would eventually give ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results